Nipro Pharma Corp., a CMO based in Osaka, Japan, began operations at a new 4,752m2 facility dedicated to inspection and packaging at its Ise Plant in Mie prefecture, Japan. The new facility is in response to the increase of pharmaceuticals produced outside Japan and supplied to the Japanese market.   Nipro Pharma supplies inspection and packaging services for injection and oral dosage forms to foreign pharmaceutical companies entering into the Japanese market, including inspection and packagin...